Olympus (7733) Company presentation summary

Corporate philosophy and global presence

• Purpose centers on making lives healthier, safer, and more fulfilling, guided by core values of innovation, patient focus, integrity, impact, and empathy.

• Operates in 40 countries or regions with 28,138 employees as of March 2026.

• Recognized as a top 100 global innovator and recipient of 296 design awards.

• Holds over 15,000 patents across its product portfolio.

Business fields and financial performance

• Two main divisions: Gastrointestinal Solutions (69% of revenue) and Surgical & Interventional Solutions (31%).

• FY2026 consolidated revenue reached ¥1,010.7 billion.

• Major markets include North America (40% of revenue), Europe (28%), and Japan (10%).

• Treats approximately 100 diseases or conditions, with a strong presence in lung, colorectal, and stomach cancer care.

Strategic direction and innovation

• Focused on expanding minimally invasive endoscopy-enabled care, leveraging AI, robotics, and digital healthcare solutions.

• Accelerating investments in AI-powered endoscopy (OLYSENSE) and robotic endoluminal solutions.

• Aims for 5% annual revenue growth by FY29, >10% EPS CAGR from FY2026, and ~100 bps yearly operating margin improvement.

• Strategic pillars include simplicity, accountability, and innovation-driven growth.